| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.12 | 6e-05 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |